Substance
ROFLUMILAST
Global reference: every product and company linked to this substance.
- cas: 162401-32-3
- ncit: C76890
- pubchem_cid: 449193
- rxnorm: 1091836
- unii: 0P6C6ZOP5U
ARQ-151 · ARQ-154 (Roflumilast foam) · B-9302-107 · B9302-107 · BY-217 · BY217 · BYK-20869 · BYK20869 · DALIRESP · DAXAS · roflumilast [INN] · ROFLUMILAST [JAN]
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC. COMMON STOCK | ZORYVE | Q2 2026 | $129.9M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- DALIRESP · ASTRAZENECA PLC ORDINARY SHARES
- ZORYVE · ARCUTIS BIOTHERAPEUTICS INC. COMMON STOCK